drugset / Trial / NCT02160067
A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to obtain pharmacokinetic data for a dose proportionality and relative bioavailability assessment of 2nd generation BTDS patches compared to 1st generation BTDS patches.
Timeline
- Start
- 2014-05
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 3.15 mg | Other |
| Subject | Buprenorphine | Other / unclassified | 5 mg | Other |
| Subject | Buprenorphine | Other / unclassified | 12.6 mg | Other |
| Subject | Buprenorphine | Other / unclassified | 20 mg | Other |
Indications
No indication recorded.